Measles Research Today is a free monthly online journal that collates and summarizes the latest research about Measles, including details on german measles, symptoms, vaccine, treatment, rubella.

Volume 6 (2009), Issue 6 (June)

1. An audit of vaccination coverage among vaccination service workers in Puglia, Italy.
   Am J Infect Control, 37(5): 414-6. [Abstract] [Full-text]
2. Intravascularly administered RGD-displaying measles viruses bind to and infect neovessel endothelial cells in vivo.
   Mol Ther, 17(6): 1012-21. [Abstract] [Full-text]
3. Serum and cerebrospinal fluid cytokine concentrations in subacute sclerosing panencephalitis.
   Brain Dev. [Abstract] [Full-text]
4. Successful treatment of encephalopathy and myoclonus with levetiracetam in a case of subacute sclerosing panencephalitis.
   J Child Neurol, 24(6): 763-7. [Abstract] [Full-text]
5. Prostate-specific membrane antigen retargeted measles virotherapy for the treatment of prostate cancer.
   Prostate, 69(10): 1128-41. [Abstract] [Full-text]
6. Reduced ability of hemagglutinin of the CAM-70 measles virus vaccine strain to use receptors CD46 and SLAM.
   Vaccine, 27(29): 3838-48. [Abstract] [Full-text]
7. Ethnicity and incidence of Hodgkin lymphoma in Canadian population.
   BMC Cancer, 9: 141. [Abstract] [Full-text]
8. Measles risk groups in Spain: implications for the European measles-elimination target.
   Vaccine, 27(30): 3927-34. [Abstract] [Full-text]
9. The impact of maternal measles-rubella immunization on the 12-month-old infant's immune response to measles-mumps-rubella vaccine immunogenicity.
   Eur J Clin Microbiol Infect Dis, 28(7): 845-7. [Abstract] [Full-text]
10. Scheduling of measles vaccination in low-income countries: projections of a dynamic model.
    Vaccine, 27(31): 4090-8. [Abstract] [Full-text]
11. Predictors of defaulting from completion of child immunization in south Ethiopia, May 2008: a case control study.
    BMC Public Health, 9: 150. [Abstract] [Full-text]
12. Varicella vaccination in Europe - taking the practical approach.
    BMC Med, 7: 26. [Abstract] [Full-text]
13. Development of the rubella vaccine and vaccination strategy in Japan.
    Vaccine, 27(24): 3232-3. [Abstract] [Full-text]
14. The strategy for prevention of measles and rubella prevalence with measles-rubella (MR) vaccine in Japan.
    Vaccine, 27(24): 3234-6. [Abstract] [Full-text]
15. Achieving measles control: lessons from the 2002-06 measles control strategy for Uganda.
    Health Policy Plan, 24(4): 261-9. [Abstract] [Full-text]
16. Evaluation of chikusetsusaponin IVa isolated from Alternanthera philoxeroides for its potency against viral replication.
    Planta Med, 75(8): 829-35. [Abstract] [Full-text]
17. A shared interface mediates paramyxovirus interference with antiviral RNA helicases MDA5 and LGP2.
    J Virol, 83(14): 7252-60. [Abstract] [Full-text]
18. Cytokine imbalance after measles virus infection has no correlation with immune suppression.
    J Virol, 83(14): 7244-51. [Abstract] [Full-text]
19. Genetic characterization of Chinese measles vaccines by analysis of complete genomic sequences.
    J Med Virol, 81(8): 1477-83. [Abstract] [Full-text]

© 2004-2010 Measles Research Today. All Rights Reserved.